We are live on ! Find out more
GT

Glenview Trust Portfolio holdings

AUM $6.37B
1-Year Est. Return 23.72%
This Fund
S&P 500
This Quarter Est. Return
+5.98%
1 Year Est. Return
+23.72%
3 Year Est. Return
+87.8%
5 Year Est. Return
+115.86%
10 Year Est. Return
AUM
$5.2B
AUM Growth
+$228M
Cap. Flow
-$26.5M
Cap. Flow %
-0.51%
Top 10 Hldgs %
34.38%
Holding
485
New
22
Increased
199
Reduced
181
Closed
11

Top Sells

Rank Stock Value
1
BF.B icon
Brown-Forman Class B
BF.B
+$81.1M
2
TMO icon
Thermo Fisher Scientific
TMO
+$14.5M
3
DLTR icon
Dollar Tree
DLTR
+$14.3M
4
NVDA icon
NVIDIA
NVDA
+$12.5M
5
LLY icon
Eli Lilly
LLY
+$2.75M

Sector Composition

Rank Sector Weight
1 Technology 24.1%
2 Healthcare 11.1%
3 Financials 9.78%
4 Consumer Staples 6.93%
5 Consumer Discretionary 6.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBMQ icon
276
iShares iBonds Dec 2028 Term Muni Bond ETF
IBMQ
$658M
$933K 0.02%
36,400
IWO icon
277
iShares Russell 2000 Growth ETF
IWO
$14.3B
$926K 0.02%
3,261
-268
-8% -$73.4K
VYM icon
278
Vanguard High Dividend Yield ETF
VYM
$80.9B
$915K 0.02%
7,137
+19
+0.3% +$2.35K
CLX icon
279
Clorox
CLX
$11.6B
$913K 0.02%
5,604
+760
+16% +$113K
LAMR icon
280
Lamar Advertising Co
LAMR
$16.2B
$911K 0.02%
6,822
-806
-11% -$98.4K
IWV icon
281
iShares Russell 3000 ETF
IWV
$19.6B
$905K 0.02%
2,771
CSL icon
282
Carlisle Companies
CSL
$14.6B
$895K 0.02%
1,990
HSY icon
283
Hershey
HSY
$35.5B
$878K 0.02%
4,578
+923
+25% +$179K
VRSK icon
284
Verisk Analytics
VRSK
$25.4B
$878K 0.02%
3,275
+548
+20% +$148K
OTIS icon
285
Otis Worldwide
OTIS
$27.4B
$873K 0.02%
8,395
-175
-2% -$16.7K
DD icon
286
DuPont de Nemours
DD
$18.5B
$823K 0.02%
7,355
VTEB icon
287
Vanguard Tax-Exempt Bond Index Fund
VTEB
$45.1B
$822K 0.02%
16,086
+4,957
+45% +$251K
MDEV icon
288
First Trust Indxx Medical Devices ETF
MDEV
$3.04M
$821K 0.02%
36,870
TSLA icon
289
Tesla
TSLA
$1.23T
$819K 0.02%
3,131
-1,474
-32% -$336K
GSSC icon
290
GS ActiveBeta US Small Cap Equity ETF
GSSC
$1.04B
$804K 0.02%
11,599
+1,838
+19% +$123K
NOC icon
291
Northrop Grumman
NOC
$77.1B
$796K 0.02%
1,507
XLF icon
292
State Street Financial Select Sector SPDR ETF
XLF
$56.7B
$790K 0.02%
17,424
+965
+6% +$42.1K
ARCC icon
293
Ares Capital
ARCC
$13.5B
$788K 0.02%
37,637
-2,000
-5% -$41.5K
COF icon
294
Capital One
COF
$128B
$762K 0.01%
5,090
-921
-15% -$131K
IBMN
295
DELISTED
iShares iBonds Dec 2025 Term Muni Bond ETF
IBMN
$750K 0.01%
28,148
ZTS icon
296
Zoetis
ZTS
$32.4B
$745K 0.01%
3,811
-228
-6% -$42K
KKR icon
297
KKR & Co
KKR
$91.1B
$744K 0.01%
5,699
+745
+15% +$88.1K
ELV icon
298
Elevance Health
ELV
$81.5B
$743K 0.01%
1,429
-29
-2% -$15.5K
IBDV icon
299
iShares iBonds Dec 2030 Term Corporate ETF
IBDV
$3.26B
$743K 0.01%
33,500
+3,250
+11% +$70.9K
VGSH icon
300
Vanguard Short-Term Treasury ETF
VGSH
$29.3B
$741K 0.01%
12,561
-2,550
-17% -$149K

Similar funds

Glenview Trust's Q3 2024 Portfolio in Review

As of Q3 2024, Glenview Trust held 485 positions worth $5.2B, up 4.6% from $4.97B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Glenview Trust's Q3 2024 filing shows 22 new, 199 increased, 181 reduced and 11 closed positions. Its largest new stake was State Street SPDR S&P 600 Small Cap Value ETF: 5,496 shares worth $477K. The largest sale was Brown-Forman Class B, an estimated $81.1M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.

  • Glenview Trust's largest Q3 2024 buy was State Street SPDR S&P 600 Small Cap Value ETF: 5,496 shares worth $477K.
  • Glenview Trust added most to Becton Dickinson in Q3 2024, an estimated $17.3M increase.
  • Glenview Trust's biggest Q3 2024 reduction was Brown-Forman Class B, cutting an estimated $81.1M.
  • Glenview Trust fully exited Microchip Technology in Q3 2024, selling an estimated $617K.
  • Glenview Trust's ten largest holdings make up 34% of its $5.2B portfolio in Q3 2024.
  • Glenview Trust opened 22 new positions and closed 11 in Q3 2024.
  • Glenview Trust's portfolio value rose 4.6% quarter-over-quarter to $5.2B.

Based on Glenview Trust's 13F filing for Q3 2024, filed 12 Nov 2024.